Завтра

@VENOM_TOM во сколько

SAN DIEGO--(BUSINESS WIRE)-- Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it will report its second quarter 2021 financial results on Monday, August 9, 2021. In connection with the earnings release, Gossamer’s management team will host a live conference call and webcast at 4:30 p.m. ET on Monday, August 9, 2021, to discuss the Company’s financial results and provide a corporate update.

14-30 10.08

@BOY32167 сегодня в 23:30!!!